Editor’s note: This is a developing news story. Please check back soon for updates. Total30 multifocal for astigmatism, a monthly toric lens for patients with presbyopia, is now available in the U.S., according to a press release from Alcon. The lens features Alcon’s water gradient technology, enabling its surface to be “nearly 100%” water, as well as ultraviolet blocking and blue-violet light filtration, according to the release. It also uses Alcon’s Celligent technology to work against bacteria and lipid deposits. The lens leverages the company’s Precision

Editor’s note: This is a developing news story. Please check back soon for updates. Total30 multifocal for astigmatism, a monthly toric lens for patients with presbyopia, is now available in the U.S., according to a press release from Alcon. The lens features Alcon’s water gradient technology, enabling its surface to be “nearly 100%” water, as well as ultraviolet blocking and blue-violet light filtration, according to the release. It also uses Alcon’s Celligent technology to work against bacteria and lipid deposits. The lens leverages the company’s Precision

Expert witnesses discussed the impact of federal regulations and administrative burden on physician burnout in a recent hearing held by the U.S. Senate Special Committee on Aging. “Today, we will look at how Washington’s regulations and red tape play into this crisis, and what we can do to fix it so our doctors can spend more time caring for patients and less time navigating bureaucracy,” committee chairman Sen. Rick Scott (R-Fla.), said in his opening statement. “We’ll hear from witnesses who interact with physicians at all levels.” Key points of discussion included difficulties managing

Expert witnesses discussed the impact of federal regulations and administrative burden on physician burnout in a recent hearing held by the U.S. Senate Special Committee on Aging. “Today, we will look at how Washington’s regulations and red tape play into this crisis, and what we can do to fix it so our doctors can spend more time caring for patients and less time navigating bureaucracy,” committee chairman Sen. Rick Scott (R-Fla.), said in his opening statement. “We’ll hear from witnesses who interact with physicians at all levels.” Key points of discussion included difficulties managing

Objective In retrocaruncular medial decompression, the incision is small relative to the depth of the surgical space, and haemorrhage may obscure vision. Measures that minimise bleeding are most important to improve visualisation and facilitate the procedure. Despite this, there is no consensus regarding the effect of nasal packing with a vasoconstrictive agent. The aim of this study was to see if haemorrhage during external medial decompression could be reduced by nasal packing. Methods and analysis A randomised, non-blinded, prospective study in which patients listed for orbital medial wall decompression at St Erik Eye Hospital, Sweden, were recruited. Patients were randomised to receive either nasal packing with a 4%+0.02% Cocaine Hydrochloride-Adrenaline solution or the control group. Intraoperative bleeding was quantified by weighing the suction device before and after the procedure. Results A total of 46 medial orbital wall decompressions in 37 patients were included in the final analysis. The treatment group, which received nasal packing, demonstrated significantly reduced intraoperative bleeding compared with the control group (median 9.40 g vs 30.10 g, p

Publication date: Available online 17 February 2026 Source: Experimental Eye Research Author(s): Chia-Ying Tsai, Shang-Chih Yang, Wei-Lun Huang, Yi-Ting Hou, Vladlen Klochkov, Mei-Yun Chen, Shu-Lang Liao, Wei-Li Chen

In the originally published article, the Funding/Support information was incorrect. The Funding/Support section should be corrected as follows.

.

.

.

To evaluate the risk of demyelinating disease and optic neuritis among patients treated with TNF-α inhibitors using a large, nationwide electronic health record database.

The Rabb-Venable program is a research mentorship initiative established in 2000 to foster interest in ophthalmology. This report demonstrates the program’s contributions to workforce diversity and offers an overview of the alumni’s practice locations.

Evaluates visual outcomes following small-aperture intraocular lens implantation in post-refractive surgery patients undergoing cataract surgery

A female infant (gestational age 31 weeks, birth weight 1350 g) with aggressive retinopathy of prematurity (A-ROP) developed severe posterior vitreous contraction and traction, a vision-threatening complication known as the “crunch” effect, two weeks after intravitreal ranibizumab injection (A, E). Optical coherence tomography (OCT) demonstrated macular retinoschisis rather than detachment (B, F). At 40 weeks postmenstrual age, the infant underwent pars plana vitrectomy (PPV) during which a complete posterior vitreous detachment (PVD) was induced, followed by an intraoperative anti-VEGF reinjection at the conclusion of surgery.

Following primary pediatric intraocular lens (IOL) implantation, the goal is to have sufficient hyperopic refractive error that as the child ages the resultant refractive error allows reasonable uncorrected visual acuity. In addition, there are limited data on the natural history of astigmatism following pediatric lensectomy. With the increasing use of toric intraocular lenses (IOLs) in children undergoing cataract surgery,1-3.it is important to understand changes in astigmatism over time in a child’s pseudophakic eye.

To evaluate whether a multifocal contact lens improves central-peripheral rivalry–type (CPR-type) diplopia in patients with epiretinal membrane and other maculopathies.

Describing changes in standard automated perimetry parameters before and after extended depth-of-focus intraocular lens implantation in a longitudinal study.

Jabs y otros (p.310) realizaron un ensayo aleatorio evaluativo de eficacia, para comparar el adalimumab con los medicamentos inmunosupresores convencionales para el tratamiento de la uveítis no infecciosa. El análisis de 227 participantes mostró que hubo una proporción acumulada significativamente mayor de participantes, con ahorro exitoso de corticosteroides en el grupo de adalimumab a los 6 meses, pero no a los 12 meses, en comparación con la inmunosupresión convencional. Se logró una reducción satisfactoria del uso de corticosteroides en el 69% de los pacientes asignados a adalimumab, en comparación con el 54% asignados a inmunosupresión convencional a los 6 meses, y en el 86% de los pacientes asignados a adalimumab en comparación con el 77% asignados a inmunosupresión convencional a los 12 meses.

Five years ago, our multisociety survey of North American cataract surgeons’ practices and opinions regarding operating room waste highlighted the need for ophthalmology to reduce carbon emissions and waste.1,2 Since then, discourse, research, and engagement around sustainability in eye care have increased markedly. Much of this has been chronicled and shared through the website of EyeSustain (www.eyesustain.org), a global coalition of 55 societies committed to advancing sustainability in ophthalmology through education, research, innovation, and advocacy.

Jabs et al (p. 310) conducted a randomized comparative effectiveness trial to compare adalimumab to conventional immunosuppressive drugs for treating noninfectious uveitis. Analysis of 227 participants showed that there was a significantly greater cumulative proportion of participants with successful corticosteroid sparing in the adalimumab group at 6 months but not 12 months compared to conventional immunosuppression. Adalimumab also resulted in a significantly greater cumulative proportion of individuals with successful corticosteroid discontinuation by 12 months compared to conventional immunosuppression.

Eye, Published online: 17 February 2026; doi:10.1038/s41433-026-04320-8Video-Indirect Fluorescein Angiofusion (VIFA): an emerging imaging technique for retinal vasculature

Eye, Published online: 17 February 2026; doi:10.1038/s41433-026-04330-6Response to: ‘Comment on: ‘Association between visual impairment and sleep quality: A cross-sectional, comparative study of severity, eye conditions, and risk factors”